Jim Simons Lixte Biotechnology Holdings, Inc. Transaction History

Renaissance Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.48 - $6.0 $38,430 - $480,384	-80,064 Reduced 88.31%	10,600 $5,000
Q3 2022 Nov 14, 2022	BUY	$0.12 - $5.9 $4,017 - $197,502	33,475 Added 58.53%	90,664 $51,000
Q2 2022 Aug 12, 2022	BUY	$0.12 - $0.35 $6,862 - $20,016	57,189 New	57,189 $43,000
Q3 2021 Nov 12, 2021	SELL	$0.52 - $0.85 $26,468 - $43,265	-50,900 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$0.46 - $0.89 $23,414 - $45,301	50,900 New	50,900 $154,000

Ticker LIXT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,646,600
Market Cap $33.8M
Description
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agent...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.